|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits in banks and federal funds sold | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investment securities available-for-sale, at fair value (amortized cost $400,194 and $412,395 respectively) | ||||||||||||||||||||
| Investment securities held-to-maturity, at amortized cost (fair value $331,123 and $354,290, respectively) | ||||||||||||||||||||
| Other investments | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans, net of unearned income | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Loans, net | ||||||||||||||||||||
| Premises and equipment | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets | ||||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and stockholders' equity | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Federal Home Loan Bank advances | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Preferred stock, no par value; 10,000,000 shares authorized, none issued or outstanding as of September 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Common stock, par value $1.00 per share; 50,000,000 shares authorized, 17,567,983 and 17,598,123 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Preferred stock, no par value; 10,000,000 shares authorized, none issued or outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Common stock, par value $1.00 per share; 50,000,000 shares authorized, 21,158,353 and 21,251,695 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of tax | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
| Common stock, shares authorized (in shares) | ||||||||||||||||||||
Loading...
